Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

TPLC - Total Product Life Cycle
  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

New Search show TPLC since Back to Search Results
Device cancer-related germline gene mutation detection system
Definition The germline gene mutation test system is an in vitro diagnostic nucleic acid amplification and detection system for the identification of genetic mutations in DNA extracted from human clinical specimens.
Product CodePJG
Device Class 3

Premarket Approvals (PMA)
2021 2022 2023 2024 2025 2026
3 5 1 2 0 1

MDR Year MDR Reports MDR Events
2022 1 2

Patient Problems MDRs with this Patient Problem Events in those MDRs
Emotional Changes 1 2

-
-